Irvine, CA, United States of America

Joseph S Adorante


Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 187(Granted Patents)


Company Filing History:


Years Active: 1996-2017

Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Joseph S. Adorante: Innovator in Pharmaceutical Research**

Introduction

Joseph S. Adorante is a prominent inventor based in Irvine, CA, known for his significant contributions to pharmaceutical innovations. With a total of 26 patents to his name, Adorante has demonstrated a strong commitment to advancing medical science through his research and inventions.

Latest Patents

Among his latest patents is the groundbreaking work on "Benzimidazole derivatives as selective blockers of persistent sodium current." This invention is focused on a compound of Formula I or a pharmaceutically acceptable salt thereof. It offers promising pharmaceutical compositions for treating conditions mediated by elevated persistent sodium current, including ocular disorders, multiple sclerosis, seizure disorders, and chronic pain. The potential of this invention paves the way for new therapies aimed at alleviating these challenging medical conditions.

Career Highlights

Throughout his career, Joseph S. Adorante has made significant strides in pharmaceutical research and development. He has held key positions in notable companies such as Allergan, Inc. and Allergan Sales, Inc., where he contributed to various innovative projects aimed at improving patient outcomes through advanced therapeutics.

Collaborations

Adorante has collaborated with several esteemed professionals in the field, including George R. Ehring and Larry Allen Wheeler. These collaborations have greatly enhanced his work, leading to a fruitful exchange of ideas and innovation in pharmaceutical development.

Conclusion

Joseph S. Adorante's contributions to the field of pharmaceuticals exemplify the impact of dedicated research and innovative thinking. With 26 patents to his name and a focus on addressing complex medical issues, he continues to be a key player in the advancement of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…